Ultralife (NASDAQ:ULBI) PT Raised to $14.00
Ultralife (NASDAQ:ULBI – Get Free Report) had its target price raised by research analysts at Benchmark from $13.00 to $14.00 in a research report issued on Thursday, Benzinga reports. The firm currently has a “buy” rating on the technology company’s stock. Benchmark’s target price suggests a potential upside of 31.83% from the company’s previous close. […]
More Stories
Prudential Financial, Inc. (NYSE:PRU) Receives Average Rating of “Hold” from Analysts
Prudential Financial, Inc. (NYSE:PRU – Get Free Report) has earned an average rating of “Hold” from the twelve ratings firms...
Analysts Set Bausch + Lomb Co. (NYSE:BLCO) Price Target at $19.14
Shares of Bausch + Lomb Co. (NYSE:BLCO – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from...
The Charles Schwab Co. (NYSE:SCHW) Given Consensus Recommendation of “Hold” by Brokerages
The Charles Schwab Co. (NYSE:SCHW – Get Free Report) has been given a consensus recommendation of “Hold” by the sixteen...
Brokerages Set RPM International Inc. (NYSE:RPM) Price Target at $122.22
RPM International Inc. (NYSE:RPM – Get Free Report) has received a consensus rating of “Hold” from the nine research firms...
Elon Musk to Attend Trump Rally at Site of Attempted Assassination
By Zachary Stieber Elon Musk said on Oct. 3 that he will attend former President Donald Trump’s upcoming rally in...
Explainer: The journey of a UN Security Council resolution
How does a Security Council resolution get adopted? https://ift.tt/EjGZlry